Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD
Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With Von Willebrand Disease (VWD)
Sponsor: Octapharma
A PHASE3 clinical study on Von Willebrand Diseases, this trial is completed. The trial is conducted by Octapharma and has accumulated 15 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Nov 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Sep 2022 — Nov 2023 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
▶ Show 10 earlier versions
-
Mar 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE3
-
Oct 2021 — Mar 2022 [monthly]
Active Not Recruiting PHASE3
-
Sep 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
May 2021 — Sep 2021 [monthly]
Recruiting PHASE3
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE3
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jun 2020 — Oct 2020 [monthly]
Not Yet Recruiting PHASE3
-
Feb 2020 — Jun 2020 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2020 — Feb 2020 [monthly]
Not Yet Recruiting PHASE3
Status: Enrolling By Invitation → Not Yet Recruiting
-
Sep 2019 — Jan 2020 [monthly]
Enrolling By Invitation PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Octapharma
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Atlanta, United States , Beirut, Lebanon , Budapest, Hungary , Debrecen, Hungary , Homyel, Belarus , Kirov, Russia , Kyiv, Ukraine , Lviv, Ukraine , Moscow, Russia , Sofia, Bulgaria and 3 more locations